Effective and Cheaper Treatment for Rheumatoid Arthritis

Introduction

Rheumatoid arthritis (RA) is a chronic auto-immune disease that causes pain and stiffness in the joints, fatigue, bone damage and, eventually, loss of mobility. RA afflicts around 1% of people in the western world; in Belgium, 80,000 to 100,000 people currently live with the disease.

Main Digest

Because there is no known cure for RA, physicians focus treatment on suppressing disease activity. Therapies have improved in recent years, and clinical studies show that intensive treatment of early RA can prevent joint damage and improve patients' quality of life.

In the two-year study, called 'CareRA' (Care in early RA), researchers and clinicians in the rheumatology unit at University Hospitals Leuven examined various therapies for early RA.

The Goal

To find the optimal combination and dosage of three commonly prescribed antirheumatic drugs (methotrexate, sulfasalazine and leflunomide) in combination with glucocorticoids (a class of steroid hormones).

The researchers divided 290 early RA patients into three treatment groups. Each group received a different combination therapy:

• 'COBRA Classic' (methotrexate, sulfasalazine and a high first dose of glucocorticoids),
• 'COBRA Slim' (methotrexate and a moderate dose of glucocorticoids)
• or 'COBRA Avant-Garde' (methotrexate, leflunomide and a moderate dose of glucocorticoids).

Fewer Side Effects

All three strategies showed a similarly high efficacy: disease remission was achieved in 7 in 10 patients after 16 weeks of treatment. But results for the strategies varied significantly when it came to side effects.

The new COBRA Slim strategy, which calls for the least amount of medication, had half as many side effects as the two other strategies - and was just as effective. The strategy would also be easier to implement in daily practice because it is less complicated.

A broader use of this strategy would lead to higher remission rates in the global early RA population and would probably reduce the need for expensive second-line antirheumatic treatment, say the researchers.

"One surprising finding in the study was the high remission values recorded for all of the applied intensive treatment strategies, which were unprecedented internationally," says Diederik De Cock, doctoral researcher at the Research Center for Skeletal Biology and Engineering (KU Leuven).

"Methotrexate is very affordable, as are steroids," says Diederik De Cock.

"Implementing this therapy across Flanders would mean substantial savings. At the moment, RA treatment is not yet adequately standardized in Belgium, and this leads to treatment inefficiencies. As a result, more patients require expensive second-line antirheumatic therapies known as biologicals, which can cost up to 15,000 euros per year. By comparison, the COBRA Slim strategy costs less than 1,000 euros. In other words, we can treat up to 15 patients for the same price as a year of treatment with a biological," says Diederik De Cock.

This research benefited from the support of the IWT (Agency for Innovation by Science and Technology) and the Pfizer Chair for Early Rheumatoid Arthritis Management at the KU Leuven held by Professor Patrick Verschueren. The study was conducted in partnership with various rheumatology centers in Flanders.

Attribution/Source(s):

This quality-reviewed publication titled Effective and Cheaper Treatment for Rheumatoid Arthritis was chosen for publishing by Disabled World's editors due to its relevance to the disability community. While the content may have been edited for style, clarity, or brevity, it was originally authored by KU Leuven and published 2014/11/11 (Edit Update: 2021/04/03). For further details or clarifications, you can contact KU Leuven directly at med.kuleuven.be Disabled World does not provide any warranties or endorsements related to this article.

Related Publications


Share This Information To:
𝕏.com Facebook Reddit

Page Information, Citing and Disclaimer

Disabled World is an independent disability community founded in 2004 to provide news and information to people with disabilities, seniors, their family and carers. You can connect with us on social media such as X.com and Facebook.

Cite This Page (APA): KU Leuven. (2014, November 11). Effective and Cheaper Treatment for Rheumatoid Arthritis. Disabled World. Retrieved May 17, 2024 from www.disabled-world.com/health/autoimmunediseases/rheumatoid-arthritis/cobra.php

Permalink: <a href="https://www.disabled-world.com/health/autoimmunediseases/rheumatoid-arthritis/cobra.php">Effective and Cheaper Treatment for Rheumatoid Arthritis</a>: New drug combination for RA treats the disease with less medication and fewer side effects at significantly lower cost.

Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.